LRMR - Larimar Therapeutics, Inc.

QQQ $ 454.82 $ 9.16 (2.02 %)

DIA $ 398.57 $ 1.02 (0.26 %)

SPY $ 530.36 $ 6.28 (1.19 %)

TLT $ 91.26 $ 0.68 (0.73 %)

GLD $ 225.37 $ 2.55 (1.18 %)

Previous Close

$ 9.89

Open

$ 9.70

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 9.38 - $ 9.94

52 Week Range

$ 2.18 - $ 13.68

Volume

609,032

Average Volume

Market Cap

529.65M

Beta (5Y Monthly)

$ 0.96

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-09-2024	03-31-2024	10-Q
2	03-14-2024	12-31-2023	10-K
3	11-14-2023	09-30-2023	10-Q
4	08-10-2023	06-30-2023	10-Q
5	05-15-2023	03-31-2023	10-Q
6	03-14-2023	12-31-2022	10-K
7	11-10-2022	09-30-2022	10-Q
8	08-11-2022	06-30-2022	10-Q
9	05-12-2022	03-31-2022	10-Q
10	03-25-2022	12-31-2021	10-K
11	11-12-2021	09-30-2021	10-Q
12	08-12-2021	06-30-2021	10-Q
13	05-10-2021	03-31-2021	10-Q
14	03-04-2021	12-31-2020	10-K
15	11-12-2020	09-30-2020	10-Q
16	08-14-2020	06-30-2020	10-Q
17	05-07-2020	03-31-2020	10-Q
18	03-05-2020	12-31-2019	10-K
19	11-06-2019	09-30-2019	10-Q
20	08-08-2019	06-30-2019	10-Q
21	05-09-2019	03-31-2019	10-Q
22	03-14-2019	12-31-2018	10-K
23	11-09-2018	09-30-2018	10-Q
24	08-09-2018	06-30-2018	10-Q
25	05-10-2018	03-31-2018	10-Q
26	03-09-2018	12-31-2017	10-K
27	11-07-2017	09-30-2017	10-Q
28	08-09-2017	06-30-2017	10-Q
29	05-09-2017	03-31-2017	10-Q
30	03-10-2017	12-31-2016	10-K
31	11-09-2016	09-30-2016	10-Q
32	08-05-2016	06-30-2016	10-Q
33	05-10-2016	03-31-2016	10-Q
34	03-15-2016	12-31-2015	10-K
35	11-13-2015	09-30-2015	10-Q
36	08-14-2015	06-30-2015	10-Q
37	05-14-2015	03-31-2015	10-Q
38	03-25-2015	12-31-2014	10-K
39	11-13-2014	09-30-2014	10-Q
40	08-14-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

why-sentinelone-shares-are-trading-lower-by-16-here-are-other-stocks-moving-in-fridays-mid-day-session

Why SentinelOne Shares Are Trading Lower B...
05/31/2024 17:17:02

JMP Securities Reiterates Market Outperfor...
05/31/2024 15:46:26

JMP Securities analyst Jonathan Wolleben reiterates Larimar Therapeutics (NASDAQ:LRMR) with a Market Outperform and maintain...

ambarella-posts-upbeat-results-joins-gap-pagerduty-elastic-and-other-big-stocks-moving-higher-on-friday

Ambarella Posts Upbeat Results, Joins Gap,...
05/31/2024 14:40:33

Larimar Therapeutics Selected By FDA To Pa...
05/30/2024 20:35:28

START is a new milestone-driven program designed to accelerate development of novel therapies intended to address an unmet medi...

hello-group-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session

Hello Group And Other Big Stocks Moving Lo...
05/28/2024 09:45:35

Citigroup Maintains Buy on Larimar Therape...
05/22/2024 17:50:00

Citigroup analyst Samantha Semenkow maintains Larimar Therapeutics (NASDAQ:LRMR) with a Buy and raises the price target from...

larimar-therapeutics-friedreichs-ataxia-investigational-drug-differentiated-from-biogens-marketed-drug

Larimar Therapeutics' Friedreich's Ataxia ...
05/21/2024 18:39:04

Larimar Therapeutics announces FDA lift of partial clinical hold on nomlabofusp (CTI-1601) for Friedreich's Ataxia. Data fr...

why-james-hardie-industries-shares-are-trading-lower-by-around-14-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Why James Hardie Industries Shares Are Tra...
05/21/2024 17:36:28

JMP Securities Reiterates Market Outperfor...
05/21/2024 16:37:06

JMP Securities analyst Jonathan Wolleben reiterates Larimar Therapeutics (NASDAQ:LRMR) with a Market Outperform and maintain...

xpeng-posts-strong-results-joins-larimar-therapeutics-transcat-and-other-big-stocks-moving-higher-on-tuesday

XPeng Posts Strong Results, Joins Larimar ...
05/21/2024 14:38:35

why-larimar-therapeutics-shares-are-trading-higher-by-18-here-are-20-stocks-moving-premarket

Why Larimar Therapeutics Shares Are Tradin...
05/21/2024 12:12:19

12-health-care-stocks-moving-in-tuesdays-pre-market-session

12 Health Care Stocks Moving In Tuesday's ...
05/21/2024 12:06:31

12-health-care-stocks-moving-in-mondays-after-market-session

12 Health Care Stocks Moving In Monday's A...
05/20/2024 20:31:10

FDA Removed Partial Clinical Hold For Lari...
05/20/2024 20:07:04

Food and Drug Administration (FDA) removed partial clinical hold following review of Phase 2 dose exploration study dataOngoing...

Larimar Therapeutics' Cash, Cash Equivalen...
05/09/2024 11:39:00

Larimar Therapeutics Q1 2024 GAAP EPS $(0....
05/09/2024 11:38:09

Larimar Therapeutics (NASDAQ:LRMR) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of ...

Leerink Partners Initiates Coverage On Lar...
04/03/2024 13:18:00

Leerink Partners analyst Joori Park initiates coverage on Larimar Therapeutics (NASDAQ:LRMR) with a Outperform rating and an...

JMP Securities Reiterates Market Outperfor...
03/15/2024 14:37:46

JMP Securities analyst Jonathan Wolleben reiterates Larimar Therapeutics (NASDAQ:LRMR) with a Market Outperform and maintain...

Recap: Larimar Therapeutics Q4 Earnings
03/14/2024 21:15:07

Larimar Therapeutics Q4 EPS $(0.30) Misses...
03/14/2024 20:15:18

Larimar Therapeutics (NASDAQ: LRMR) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate ...